Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
Ruzzo A, Graziano F, Bagaloni I, Di Bartolomeo M, Prisciandaro M, Aprile G, Ongaro E, Vincenzi B, Perrone G, Santini D, Fornaro L, Vivaldi C, Tomasello G, Loupakis F, Lonardi S, Fassan M, Valmasoni M, Sarti D, Lorenzini P, Catalano V, Bisonni R, Del Prete M, Collina G, Magnani M.
Ruzzo A, et al. Among authors: lorenzini p.
Gastric Cancer. 2020 Nov;23(6):1064-1074. doi: 10.1007/s10120-020-01078-0. Epub 2020 May 5.
Gastric Cancer. 2020.
PMID: 32372141
Free PMC article.